Oventus Medical capital raising

Oventus Medical capital raising

McCullough Robertson’s Corporate Advisory team has successfully completed a $9 million capital raising for Oventus Medical Limited (Oventus).

Oventus is a Brisbane based medical device company that is commercialising a suite of oral appliances for the treatment of sleep apnoea and snoring. Unlike other oral appliances, the Oventus devices have a unique and patented airway within the device that delivers air to the back of the mouth bypassing multiple obstructions from the nose, soft palate and tongue. They are particularly designed for the many people that have nasal obstructions and consequently tend to mainly breathe through their mouth.

The money raised will go towards completing current clinical trials and completing research and development and regulatory approvals for current products in development amongst other uses.

Our team has advised Oventus since their $12 million IPO in July 2016. 

The deal was led by Partner Reece Walker with the assistance of Senior Associates Ben Wood and Lawyer Naomi Benton.

In this section